Emerald Health Therapeutics Inc. (TSX.V:EMH) Projects Annual Sales of $50million

It's a race to riches that has just begun among a handful of Canada’s licensed, industrial-scale medical marijuana growers – each of whom wants to capitalize on in-house IP that can turn cannabis into mainstream medicine. In the quest to find the next GW, Dundee Capital Markets is championing Emerald Heath Therapeutics Inc.

Courtagen Launches New Avantra Genetics Division

Courtagen Life Sciences, Inc., has launched Avantra Genetics. Avantra is dedicated to providing advanced genomic information for functional medicine practices. Patients suffering from functional disorders may experience symptoms such as pain, fatigue, numbness or sensations and gastrointestinal distress that can be severe, chronic or debilitating.

Tetra Bio-Pharma Starts Phase I Clinical Study of Smoked Cannabis.

Tetra Bio-Pharma (CSE: TBP) (CSE: TBP.CN), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that Health Canada has approved its Phase I clinical study of smoked cannabis.

Valens GroWorks Enters Into $1.2m Loan Repayment Agreements

 Valens GroWorks Corp. (CSE: VGW) together with its subsidiary is pleased to announce its engagement under a 5-year, renewable, Professional Services Agreement  with Arizona-based marijuana cultivation and medicinal dispensary business MKHS.

InMed's Pharmaceuticals Inc. 2017 Prospects

InMed Pharmaceuticals Inc. (CSE:IN, OTCQB:IMLFF) is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs.

Acquisitions on the Rise as Companies Increase Revenue

The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics.

As a result, M&A activity in the market is heading toward exponential growth as well.

 

Mining for Marijuana in Canada

Spirit Gold (SG.v) once an exploration stage company engaged in acquiring, exploring and evaluating mineral resource has turned their attention to Marijuana. Spirit Gold Entered Into Definitive Agreement to Acquire Northern Lights Marijuana Company.

Investing In A Different Kind Of Oil

In Canada, medical marijuana patients have the option to get their medication in dried form, as a concentrated oil or even fresh. Right now there are 38 approved licensed producers of medical marijuana of which only 22 produce oil. So why should this matter to Investors?

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry

Healthcare Technology Heavily Influencing the Legal Cannabis Patient Industry 07/02/2017 14:30 PALM BEACH, Florida , February 7, 2017 /PRNewswire/ -- The injection of modern technology into the developing world of cannabis and legal medical marijuana is helping the industry climb to new heights and increase engagement with consumers, especially when it comes to cannabis patients in the medical facet of the industry.

Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada

20,142.13 89.71 (0.45%) Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada BEVERLY HILLS, CA--(Marketwired - Feb 7, 2017) - Crown Baus Capital Corp. (the "Company") ( OTC PINK : CBCA ), is a global acquisition-based conglomerate looking to aggressively capitalize on its key industry strengths.

Alliance Growth Corp. (CSE:AGC) Assembles Top-Teir Growing Team

Alliance Growth Corp. executives announce that the Company has executed the founders agreement with a private Health Canada Licensed Producer Applicant based in Ontario, Canada.

The next step is a $25,000 first payment for the equity investment. The agreement will include long term plantlet supply contract and an off-take agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.

Crown Baus (OTC:CBCA) to Spend Upwards of $6m on Greenhouse Space

Crown Baus Capital Corp. (OTC:CBCA) is negotiating investment opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada.

Phase 1 for each one acre build-out will cost approximately $300,000 to $500,000 USD with full production capacity maxing out at approximately 33,000 sq. ft.

GW Pharma Looks Better Than Ever to Investors

The world’s largest company involved with producing therapeutics derived from cannabis posted a fiscal first-quarter loss of $19.25 million.

GW Pharmaceuticals (NASDAQ:GWPH) said it lost $0.768 per American depository share (ADS) in its fiscal first quarter, well below analysts’ consensus estimate of $1.20. Each ADS represents 12 ordinary shares.